Metastatic | sciencenewsnet.in

Breaking News

New CWRU study targets suicide risk among LGBTQ+ youth in Cleveland’s child welfare, juvenile justice systems

Architect: Here’s How to Build Homes in Fire-Prone Areas

Study reveals biomarker for high risk of metastasis

BLACK HOLES CAN COOK FOR THEMSELVES, CHANDRA STUDY SHOWS

Weight-Loss Surgery Lowers Risk of Developing Complications of Liver Disease in Patients with Cirrhosis and Obesity

Study Results: Exploring Gastric Cancer Risk Through Oral Microbiomes

Children’s Hospital Los Angeles Adds Transformative Gene Therapy and Expands to 10 Treatments, Becoming the Largest Provider of Pediatric Cell and Gene Therapies on the West Coast

Cancer risk established before birth

For Osteoarthritis Patients, Radiation Can Bring Winter Weather Relief

The Miami Project to Cure Paralysis at the University of Miami Miller School of Medicine Selected as a U.S. Site for Neuralink Clinical Trial

28 Jan, 2025

Treatment for Recurrent Uterine Cancer Advances to Next Research Phase

July 31, 2024 sarah JonasResearch Results

The latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanced or recurrent endometrial cancer moves ahead to be studied further in a phase III trial.

Metastatic Prostate Cancer Research: PSMAfore follow-on study favors radioligand therapy over change to androgen receptor pathway inhibition

May 3, 2024 sarah JonasResearch Results

Follow-on analysis of results from the phase 3 PSMAfore study, along with the overall study results, support the consideration of 177Lu-PSMA-617 as a new standard treatment approach for this prevalent population of patients with mCRPC. Research led by Dana-Farber Cancer Institute and others.